Suketu Upadhyay
Director; EVP & Chief Financial Officer; Exec VP, CFO · 8 filings · Latest: May 4, 2026
INCYTE CORP
VERTEX PHARMACEUTICALS INC / MA
ZIMMER BIOMET HOLDINGS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ZBH | Upadhyay Suketu | — | Jul 16, 2026 | Proposed Sale | $92.86 | 7,668 | $712.1K | — | |
ZBH | Upadhyay Suketu | — | Jun 24, 2026 | Proposed Sale | $90.07 | 4,560 | $410.7K | — | |
ZBH | Upadhyay Suketu | — | May 19, 2026 | Proposed Sale | $86.38 | 5,373 | $464.1K | — | |
ZBH | Upadhyay Suketu | — | May 12, 2026 | Proposed Sale | $83.48 | 31,253 | $2.6M | — | |
ZBH | Suketu Upadhyay | Exec VP, CFO | Mar 6, 2026 | Option Exercise | $0.00 | 14,776 | — | 71,514 | |
ZBH | Suketu Upadhyay | Exec VP, CFO | Feb 25, 2026 | Option Exercise | $0.00 | 6,364 | — | 64,117 | |
ZBH | Suketu Upadhyay | Exec VP, CFO | Feb 20, 2026 | Option Exercise | $0.00 | 5,445 | — | 60,199 |